Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Extension Study of E7389 for Locally Advanced or Metastatic Breast Cancer

NCT00965523 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT00965523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00965523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Extension Study of E7389 for Locally Advanced or Metastatic Breast Cancer
Lead sponsor
Eisai Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
January 31, 2011
Enrollment
81 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer